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Abstract
Background: Objective: To compare the risk of placenta previa at second birth among women who had a
cesarean section (CS) at first birth with women who delivered vaginally.
Methods: Retrospective cohort study of 399,674 women who gave birth to a singleton first and second baby
between April 2000 and February 2009 in England. Multiple logistic regression was used to adjust the estimates for
maternal age, ethnicity, deprivation, placenta previa at first birth, inter-birth interval and pregnancy complications.
In addition, we conducted a meta-analysis of the reported results in peer-reviewed articles since 1980.
Results: The rate of placenta previa at second birth for women with vaginal first births was 4.4 per 1000 births,
compared to 8.7 per 1000 births for women with CS at first birth. After adjustment, CS at first birth remained
associated with an increased risk of placenta previa (odds ratio = 1.60; 95% CI 1.44 to 1.76). In the meta-analysis of
37 previously published studies from 21 countries, the overall pooled random effects odds ratio was 2.20 (95% CI
1.96-2.46). Our results from the current study is consistent with those of the meta-analysis as the pooled odds ratio
for the six population-based cohort studies that analyzed second births only was 1.51 (95% CI 1.39-1.65).
Conclusions: There is an increased risk of placenta previa in the subsequent pregnancy after CS delivery at first
birth, but the risk is lower than previously estimated. Given the placenta previa rate in England and the adjusted
effect of previous CS, 359 deliveries by CS at first birth would result in one additional case of placenta previa in the
next pregnancy.
Background
Placenta previa can have serious adverse consequences
for both mother and baby, including an increased risk of
maternal and neonatal mortality[1-3], fetal growth
restriction and preterm delivery[4], antenatal and intra-
partum hemorrhage[5-7], and women may require a
blood transfusion[8] or even an emergency hysterect-
omy. It is a relatively uncommon condition, with an
overall incidence in England of 6.3 per 1000 births[9],
but incidence rates are higher among women with
advanced maternal age, multiple gestation, high parity,
or who smoke or use illegal drugs[10]. The risk of
placenta previa is also reported to be higher among
women with previous uterine surgery, including cesar-
ean section[11].
In England, cesarean sections constituted 25% of
National Health Service (NHS) deliveries during 2010,
and the rates have been rising for both primary and
emergency CS[9]. The risk of placenta previa in a preg-
nancy after a CS delivery has been reported to be
between 1.5 and 6 times higher than after a vaginal
delivery. A meta-analysis of studies published before
2000 of previous CS as a risk factor for placenta previa
found an overall odds ratio of 2.7 [10]. However, the
overall odds ratio was lower in studies that had better
adjustment for confounders[10]. A recent study from
the USA that was not included in the meta-analysis, and
which used a population-based cohort of 11 million
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pregnancies, found an adjusted odds ratio of 1.8 for all
pregnancies[12] and an adjusted odds ratio of 1.5 for
second births only[13].
Evidence about the risk of placenta previa following a
previous CS in UK women is limited to results pub-
lished 25 years ago[14]. We used the Hospital Episode
Statistics (HES), an administrative database of all admis-
sions to NHS hospitals in England, to define a popula-
tion-based cohort and to quantify the association
between CS at first birth and the risk of developing pla-
centa previa in the subsequent pregnancy. We also per-
formed a meta-analysis of the reported results in peer-
reviewed articles since 1980.
Methods
The cohort study
We used the HES dataset for nine financial years from
April 2000 to February 2009 for the cohort study. In
HES, individual patients are allocated the same identifier
for each episode of care[9] and core fields contain
patient demographics, clinical information, and hospital
administrative data. Diagnostic information is coded
using the International Classification of Diseases 10th
revision (ICD10) and operative procedures are coded
using the UK Office for Population Censuses and Sur-
veys classification, 4th revision (OPCS4). For delivery
episodes, the HES dataset also has an additional “mater-
nity tail” which includes parity, birth weight, gestational
age, method of delivery, and pregnancy outcome. How-
ever, not all records that describe a delivery episode
have data entered into this tail.
All women who gave birth to a singleton first and
second baby from 1st April 2000 to 28th February 2009
were eligible for inclusion. A delivery was defined as
an episode of care that included a relevant OPCS4
code (R17-R25) or ICD10 code (O80-O84) for the
mode of delivery, or a maternity tail with a valid date
of birth for a baby. Deliveries were coded as a cesarean
section by the relevant OPCS4 codes (R17 for primary
CS or R18 for emergency CS) or if OPCS4 codes were
not available, by the delivery method specified in the
maternity tail. If neither of the sets of codes were
available (0.5% of delivery episodes), vaginal delivery
was assumed.
We confined the analysis to NHS trusts (acute hospi-
tal organizations) that had a reasonable level of data
completeness on parity, defined as having parity infor-
mation in the maternity tail for more than 50% of the
delivery episodes in at least seven of the nine years cov-
ered in the study. NHS trusts were included if the pro-
portion of nulliparous women in that trust was between
25% and 55% (which corresponded to the overall rate in
England and Wales ± 15%[15]) to remove hospitals with
poor data quality. Women were allocated to the NHS
trusts that existed in February 2009 to take account of
previous organizational mergers.
We used the HES patient identifier to trace the sec-
ond births of those women who had been recorded as
nulliparous and who had singleton first births in identi-
fied NHS trusts. Diagnostic information for the second
birth was taken from the core HES diagnosis fields.
Cases of placenta previa were identified by the ICD10
code O44. Pregnancy complications were identified
using ICD10 codes O10, O11, O16 for pre-existing
hypertension; O13 for gestational hypertension; O14 and
O15 for pre-eclampsia and eclampsia; O24.4 and O24.9
for gestational diabetes; and O40 for polyhydramnios.
The effect of previous CS delivery on the risk of pla-
centa previa was estimated using unadjusted and
adjusted odds ratios. Multiple logistic regression was
used to calculate the odds ratios and the risk of placenta
previa adjusted for maternal age (<20, 20-29, 30-39,
≥40), maternal ethnicity (White, Asian, Black and
Other), deprivation, inter-birth interval (<1, 1-2, 2-3, 3-
4, 4-5, ≥5 years), placenta previa at first birth and indi-
cators for pregnancy complications (i.e., pre-existing
hypertension, gestational hypertension including pre-
eclampsia and eclampsia, gestational diabetes and poly-
hydramnios). Deprivation was measured using the 2004
Index of Multiple Deprivation (IMD) rank of the English
Super Output Areas. The IMD combines a range of eco-
nomic, social and housing indicators into a single depri-
vation score for each small area in England [16].
Categories were defined by partitioning the ranks of the
32,480 areas into quintiles (0-20th percentiles, 20-40th
percentiles, etc.) and labeled 1 (least deprived) to 5
(most deprived). Women were allocated a category
based on their region of residence. We calculated the
number needed to harm using the adjusted estimates
from the logistic regression[17].
We examined whether the effect of CS on placenta
previa rates was related to the level of other risk factors,
such as whether the effect of CS on the placenta previa
risk differed between younger and older women. The
significance of an interaction term between previous CS
and other risk factors was assessed with the likelihood
ratio test. All analyses were done in Stata/SE 10.0.
The study is exempt from IRB and UK NREC
approval as it involved analysis of an existing dataset
comprising information on delivery episodes for women
who cannot be identified directly or through the HES
patient numbers linked to them.
Review of literature and meta-analysis
We searched Pubmed, Embase, Web of Science, Cinahl
and the Cochrane Library for the period January 1980
to January 2011 to identify studies that examined the
relationship between previous cesarean section and
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placenta previa. The keywords of “placenta previa"/"pla-
centa praevia” and “cesarean"/"caesarean” were searched
in MESH headings, titles and abstracts to locate relevant
articles. We also checked the references of the selected
articles and previous reviews. We only included articles
written in English and limited the search to peer-
reviewed journals.
We selected studies in which placenta previa was diag-
nosed or recorded at third trimester or during delivery.
If two or more relevant articles used the same data
source in overlapping years, we selected the study that
adjusted the effect size by age or parity, and if there is
still replication, the study with the larger sample size.
Estimated log odds ratios and standard errors of log
odds ratios were calculated from raw data presented in
the included papers. The meta-analysis was performed
using a random-effects model, and summarized the
degree of consistency across the study results using the
I2 measure, the percentage of total variation across stu-
dies that is due to heterogeneity rather than chance
[18]. Meta-regression was used to assess whether the
effect size was associated with date of publication,
study design (cohort vs. case-control), source of data
(population vs. hospital based), method of diagnosis of
placenta previa (confirmed at delivery vs. recorded at
hospital or birth registry databases), and whether the
results were adjusted for age and parity. We also did a
subgroup analysis of population-based cohort studies
focusing on the association between first-birth cesar-
ean delivery and second-birth placenta previa and
compared the magnitude of this association with the
results from our cohort.
Results
The cohort study
Between April 2000 and February 2009, there were
4,987,245 singleton delivery episodes in 146 English
NHS trusts. It was necessary to exclude 76 NHS trusts
due to incomplete parity information. This left
2,484,468 (49.8%) singleton delivery episodes in 70 NHS
trusts. Of these, 958,882 (38.6%) women were nullipar-
ous and 399,674 had had a second singleton birth by
February 2009. The overall rate of placenta previa for
the cohort at first birth was 3.6 and at second birth was
5.3 per 1000 births. The proportion of women who had
undergone a CS at first birth was 21.5%. The median
birthweight at second birth was 3448 grams (Interquar-
tile range: 3110 -3780 grams).
The rate of placenta previa at second birth was 4.4 per
1000 births for women with vaginal delivery at first birth
and 8.7 for women with CS at first birth (unadjusted
odds ratio = 1.88). We found that this increased risk of
placenta previa persisted after other risk factors were
taken into account (adjusted odds ratio = 1.60) (Table
1). The strongest association between a maternal charac-
teristic and the risk of placenta previa was for women
who had placenta previa at first birth (adjusted odds
ratio = 4.77). Women with advanced maternal age, with
polyhydramnios, with very short birth intervals of less
than one year, and with birth intervals of more than
four years also had higher placenta previa risks. Women
with pre-existing hypertension had lower placenta previa
risks. Using these estimates, we expect that 359 CS
deliveries at first birth would result in one additional
case of placenta previa at second birth.
Individual interactions with categories for maternal
age, ethnicity, deprivation, maternal risk factors and
inter-pregnancy interval did not modify the size of the
effect of a previous CS on the risk of placenta previa.
Review of literature and meta-analysis
We identified 2077 articles of which 74 were of poten-
tial relevance to merit a full-text review. 41 articles were
selected for inclusion in the review, and an additional
eight articles were retrieved from reference lists
[8,12,13,19-64]. Among the 49 articles, 12 used overlap-
ping datasets with other studies and were excluded.
Study characteristics are presented in Table 2 and the
meta-analysis results from the selected 37 studies are
given in Figure 1. The overall pooled random effects
odds ratio was 2.20 (95% CI 1.96-2.46). The spread of
the odds ratios reported in the individual studies were
larger than can be expected by chance alone (I2= 87.6%).
In bi-variate meta-regressions of various study charac-
teristics on the reported odds ratios (Table 3), signifi-
cantly smaller effect size of previous cesarean section on
placenta previa was associated with recent studies (p =
0.04), population-based studies (p = 0.03), and those
that adjusted for age and parity (p = 0.04). The odds
ratios reported in the individual studies were not asso-
ciated with type of study design (cohort vs. case-control)
and method of diagnosis of placenta previa (data record
in database vs. confirmation at delivery). Heterogeneity
across studies remained in subgroup analyses by study
design, setting and timing of diagnosis of placenta pre-
via. Results from studies that adjusted for age and parity
were less heterogeneous (I2 = 52.3%) and the variation
in the results from studies that analyzed first two births
were due to chance alone (I2 = 0%).
The pooled random effects odds ratio for the six
population-based cohort studies analyzing second births
only was 1.51 (95% CI 1.39-1.65, I2 = 0%), comparable
to our cohort study.
The pooled odds ratio and association of study char-
acteristics on the odds ratio remained similar after
inclusion of the current study in the meta-analysis. The
subgroup of studies analyzing first two births had signif-
icantly smaller effect sizes (p = 0.04).
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Discussion and Conclusions
Among women in England, cesarean section in the first
delivery increased the risk of placenta previa in the sub-
sequent delivery by 60%. There was no evidence that
the effect of CS on placenta previa rates varied among
different groups of women or by the time between two
pregnancies. The risks of placenta previa in the second
pregnancy also increased by previous placenta previa,
advanced maternal age and with birth intervals of less
than one year or more than four years. Women with
pre-existing hypertension were less likely to have pla-
centa previa. Our results are consistent with recent stu-
dies from other countries which typically found odds
ratios ranging from 1.4 to 1.7.
Table 1 Maternal characteristics and rate of placenta previa (per 1000 births) in second births
Number (%) of births Placenta Previa Rate Unadjusted OR
(95% CI)**
Adjusted OR
(95% CI)**
Previous cesarean delivery p < 0.001 p < 0.001
Yes 86055 (21.5) 8.7 1.88 (1.71-2.07) 1.60 (1.44-1.76)
No 313619 (78.5) 4.4 - -
Previous placenta previa p < 0.001 p < 0.001
Yes 1429 (0.4) 43.4 7.74 (5.80-10.34) 4.77 (3.55-6.42)
No 398245 (99.6) 5.2 - -
Maternal age* p < 0.001 p < 0.001
<20 15393 (3.9) 1.9 0.56 (0.38-0.82) 0.58 (0.39-0.86)
20-29 191151 (47.8) 3.6 - -
30-39 184237 (46.1) 7.1 2.01 (1.82-2.22) 1.83 (1.65-2.05)
≥40 8887 (2.2) 13.2 3.60 (2.90-4.46) 3.01 (2.41-3.75)
Ethnicity* p = 0.053 p = 0.387
White 275181 (80.4) 5.6 - -
Asian 42486 (12.4) 4.8 0.86 (0.74-0.99) 1.03 (0.89-1.21)
Black 12158 (3.6) 5.0 0.91 (0.70-1.17) 0.96 (0.74-1.25)
Other 12448 (3.6) 6.7 1.19 (0.96-1.50) 1.22 (0.97-1.52)
Deprivation* p < 0.001 p = 0.180
Q1 Most deprived 122039 (30.6) 4.0 - -
Q2 90740 (22.8) 5.1 1.30 (1.14-1.49) 1.10 (0.96-1.26)
Q3 85913 (21.6) 6.1 1.52 (1.33-1.73) 1.15 (0.99-1.32)
Q4 Least deprived 99403 (25.0) 6.5 1.63 (1.44-1.85) 1.16 (1.01-1.33)
Pre-existing hypertension p = 0.080 p = 0.026
Yes 5730 (1.4) 3.5 0.69 (0.44-1.08) 0.62 (0.39-0.98)
No 393944 (98.6) 5.4 - -
Gestational hypertension*** p = 0.322 p = 0.098
Yes 8464 (2.1) 5.1 0.85 (0.60-1.19) 0.76 (0.54-1.07)
No 391210 (97.9) 5.3 - -
Gestational diabetes p = 0.337 p = 0.892
Yes 5586 (1.4) 5.9 1.19 (0.84-1.69) 0.98 (0.69-1.39)
No 394088 (98.6) 5.3 - -
Polyhydramnios p = 0.003 p = 0.009
Yes 1985 (0.5) 11.1 2.11 (1.35-3.28) 1.92 (1.23-3.00)
No 397689 (99.5) 5.3 - -
Inter-birth interval p < 0.001 p < 0.001
<1 7511 (1.9) 6.4 1.38 (1.02-1.87) 2.08 (1.53-2.83)
1 to 2 120803 (30.2) 4.8 0.92 (0.81-1.03) 1.01 (0.90-1.14)
2 to 3 133834 (33.5) 5.2 - -
3 to 4 73992 (18.5) 5.5 1.08 (0.95-1.23) 1.08 (0.94-1.23)
4 to 5 35557 (8.9) 6.1 1.19 (1.01-1.40) 1.19 (1.01-1.40)
≥5 27977 (7.0) 6.6 1.29 (1.09-1.53) 1.32 (1.11-1.57)
* Not including missing values (Maternal age n = 6, 0.0%; Deprivation n = 1549, 0.4%; Ethnicity n = 57401, 14.6% of data missing)
** The model was adjusted for all the variables presented in the table. P-values from the likelihood ratio test
*** Gestational hypertension includes pre-eclampsia and eclampsia
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Table 2 Characteristics of the studies included in the meta-analysis
Study ID Country Study
period
Study
design
Population Size First two
births
Risk adjustment*
Singh_1981 India 1973-1978 Cohort Hospital 12040 0 -
Gorodeski_1985 Israel 1972-1983 Case-control Hospital 455 0 -
Sauer_1985 USA 1981-1984 Case-control Hospital 135 0 -
Clark_1985 USA 1977-1983 Cohort Hospital 97799 0 -
Rose_1986 England 1978-1982 Case-control Hospital 160 0 AP;
Hemminki_1987 Sweden Cohort Population 7337 1 AP;
Nielsen_1989 Sweden 1978-1987 Cohort Hospital 24644 0 -
Williams_1991 USA 1977-1980 Case-control Hospital 12420 0 AP; abortion; alcohol and tobacco use; SE
Chattopadhyay_1993 Saudi
Arabia
1988-1992 Cohort Hospital 41206 0 -
Zhang_1993 USA 1988-1990 Case-control Population 6478 0 -
Parazzini_1994 Italy 1979-1991 Case-control Hospital 203 0 -
Makhseed_1994 Kuwait 1992-1992 Cohort Hospital 8721 0 -
Khouri_1994 Saudi
Arabia
1985-1989 Cohort Hospital 25551 0 -
Taylor_1994 USA 1984-1987 Case-control Population 1967 0 AP; abortion; tobacco use
To_1995 Hong
Kong
1984-1993 Cohort Hospital 50485 0 -
Monica_1995 Sweden 1983-1990 Case-control Population 4676 0 AP; previous previa
Hemminki_1996 Finland 1987-1993 Cohort Population 10889 1 AP; provider
Chelmow_1996 USA 1992-1994 Case-control Hospital 128 0 -
Takayama_1997 Japan 1974-1994 Case-control Hospital 264 0 -
Macones_1997 USA 1992-1996 Case-control Hospital 120 0 age; abortion; drug and tobacco use
Ziadeh_1999 Jordan 1995-1996 Cohort Hospital 18651 0 -
Hendricks_1999 Singapore 1993-1997 Cohort Hospital 16169 0 -
Rageth_1999 Switzerland 1983-1996 Cohort Population 255453 0 -
Archibong_2001 Saudi
Arabia
1997-2002 Cohort Hospital 15191 0 -
Lydon-
Rochelle_2001
USA 1987-1996 Cohort Population 95630 1 AP
Eniola_2002 Nigeria Case-control Hospital 272 0 AP; abortion; SE
Gilliam_2002 USA 1986-1989 Case-control Hospital 1171 1 AP; abortion; tobacco use
Tuzovic_2003 Croatia 1992-2001 Case-control Hospital 1206 0 -
Hossain_2004 Bangladesh 2000-2002 Cohort Hospital 2536 0 -
Olive_2005 Australia 1998-2002 Cohort Hospital 375653 0 -
Getahun_2006 USA 1989-1997 Cohort Population 156475 1 AP; abortion; alcohol and tobacco use; prenatal
care; inter pregnancy interval; SE
Kennare_2007 Australia 1998-2003 Cohort Population 36038 1 AP; abortion
Hung_2007 Taiwan 1990-2003 Cohort Hospital 37702 0 -
Daltveit_2008 Norway 1967-2003 Cohort Population 637497 1 AP; delivery date
Rahim_2009 Pakistan 2001-2005 Cohort Hospital 20110 0 -
Yang_2009 USA 1995-2000 Cohort Population 11026768 0 AP; abortion; alcohol, tobacco and drug use;
prenatal care; SE
Rosenberg_2010 Israel 1988-2009 Cohort Hospital 185476 0 AP; abortion; fertility treatment; tobacco use
* AP: age and parity; SE: socioeconomic factors
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Strengths and limitations of this study
This is the first study of placenta previa risk in England
using a large, population-based cohort of nearly 400,000
women with first two births. It included half of all sin-
gleton NHS hospital deliveries between April 2000 and
February 2009. Due to its comprehensive coverage, the
HES database is a valuable resource particularly for stu-
dies of relatively uncommon conditions such as placenta
previa.
In this study we focused only on the effect of a CS
delivery at first birth on a second pregnancy. This has
two benefits. First, it corresponds to the information
typically required by women and obstetricians. For
example, the average achieved family size in the UK is
approximately two[65], and so the effect of CS on the
second birth is more relevant and accurate than a rela-
tive risk based on all pregnancies that may include
women with multiple previous CS. Second, estimates
Figure 1 The relative risk of placenta previa associated with a previous cesarean section.
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based on all pregnancies will be influenced by the pro-
portions of women in 2nd, 3rd, 4th... pregnancies con-
tained in the study sample. Study samples may also
differ in the observed sequences of modes of delivery
(for example, due to differences in the propensity of
local women to opt for trial of labor). Both factors will
reduce the comparability of the estimates across studies.
We note that, while there is a wide range of reported
relative risks, there is consistency in the effect sizes for
studies limited to second births.
It is possible that the women with incomplete data in
the maternity tail differed from women included in the
study in terms of their characteristics and pregnancy
risks. However, the distributions of maternal age and
mode of delivery were similar in the episodes with good
quality data and omitted episodes, which suggests the
risk of selection bias is likely to be small.
The coding of the diagnoses and procedures in admin-
istrative databases is potentially inaccurate. However,
this is unlikely to have had a major effect in our study
because previous studies have reported high-levels of
agreement in the coding of cesarean section between
administrative databases and medical reviews (kappa >
0.98, where stated) [66-68]. Furthermore, cesarean deliv-
eries were defined using the first three characters of the
full 4-character OPCS codes, and broader categories
rather than specific codes have been shown to be more
reliable[69].
Just like other population-based studies, we were not
able to confirm the grade and severity of placenta previa
[70,71]. We were also not able to control for behavioral
risk factors, such as maternal smoking and alcohol and
drug use, and previous abortions [40,72-74]. However,
the effects of these risk factors as reported in the litera-
ture are small compared to the effect of prior CS,
maternal age and parity[10].
Comparison with other studies
In the previous meta-analysis of 21 studies, the pooled
odds ratios of previous CS as a risk factor for placenta
previa was found to be 2.7 (95% CI: 2.3 to 3.2). The
same study emphasized that the odds ratios were highly
variable by setting, study design, sample size and quality.
For well-designed studies, the pooled odds ratio was 1.9
(95% CI: 1.7 to 2.2)[10].
Since this review, a number of studies have been pub-
lished. 13 of the 37 studies included in our meta-analy-
sis are post-2000 and cover approximately 12 million
women. The pooled odds-ratio of 2.2 (95% CI: 2.0 to
2.5) from this meta-analysis is less than the previous
review, and reflects the fact that studies with recent
publication dates found smaller effect sizes.
Table 3 Subgroup analysis of the association between previous cesarean section and placenta previa by study
characteristics
Not including current study Including current study
Number of
Studies
Random Effects
Pooled OR
Lower
95% CI
Upper
95% CI
I2 Number of
Studies
Random Effects
Pooled OR
Lower
95% CI
Upper
95% CI
I2
Overall 37 2.199 1.964 2.462 86.1% 38 2.155 1.941 2.395 86.0%
Study design
Cohort studies 23 2.345 2.045 2.690 89.7% 24 2.284 2.014 2.591 89.5%
Case-control
studies
14 1.933 1.517 2.464 71.0% 14 1.933 1.517 2.464 71.0%
Setting
Population-based
studies
11 1.674 1.549 1.809 86.7% 12 1.664 1.553 1.785 56.0%
Hospital-based
studies
26 2.677 2.146 3.339 86.8% 26 2.677 2.146 3.339 86.8%
Timing of PP
diagnosis
Confirmed at CS 13 2.515 1.751 3.613 88.2% 13 2.515 1.751 3.613 88.2%
Other 24 1.982 1.781 2.206 80.9% 25 1.936 1.756 2.135 80.7%
Inclusion criteria
Studies analyzing
2nd births only
7 1.504 1.383 1.635 0% 8 1.540 1.442 1.645 0%
Other 30 2.462 2.138 2.835 87.6% 30 2.462 2.138 2.835 87.6%
Risk-adjustment
Adjusted for age
and parity
14 1.648 1.515 1.792 52.3% 15 1.642 1.524 1.769 54.1%
Unadjusted
estimates
23 2.712 2.174 3.383 87.7% 23 2.712 2.174 3.383 87.7%
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Our results for the English cohort are in agreement
with other recent, population-based cohorts analyzing
second-births only. In the largest population-based
cohort study of over 11 million singleton deliveries
between 1995 and 2000 in the USA, the adjusted odds
ratio of the effect of previous CS on placenta previa at
second-birth was 1.5[75]. Other population-based cohort
studies published in the last decade reported adjusted
odds ratios ranging from 1.4 to 1.7, using Missouri state
birth certificates data[26], Washington state Birth Events
data[8], South Australian Perinatal Data[37] and Medical
Birth Registry of Norway[49]. A population-based study
using data from the Swedish Birth Registry found a
higher adjusted odds ratio of 1.8, but this study did not
adequately control for risk factors[76].
A few studies have investigated whether the effect of a
previous CS on the risk of placenta previa was modified
by other risk factors. The Missouri cohort study found
that the effect of CS was 70% higher for women with a
second pregnancy within a year after the first delivery
[26]. We did not find evidence to support the hypothesis
that inter-pregnancy interval influences the size of effect
of first birth CS. Our results are consistent with the
Washington state cohort study that found the size of
effect of CS was not influenced by maternal age at sec-
ond birth [8].
Implications for policy and practice
Cesarean section rates are rising worldwide, and an
increase in the longer term complications of CS should
be anticipated. The presumed short and long term safety
of CS is probably one of the factors underlying both the
growing rate of CS and the wide variation in CS rates
not accounted for by case mix. There is a need for bet-
ter understanding of the relative risks associated with
vaginal and CS births to support decision-making by
mothers and clinicians[77].
The Confidential Enquiry into Maternal and Child
Health recommends that women with a prior CS
should have placental localization in current pregnancy
to exclude placenta previa[78]. If placenta previa is
diagnosed, there must be further investigation to
exclude placenta accreta, a potentially life-threatening
condition. In high-income countries, advanced radiolo-
gical facilities can help to diagnose this serious condi-
tion in antenatal care and to plan delivery in a tertiary
care unit. However, in low or middle-income countries,
placental conditions may be encountered first time at
the CS with its serious consequences and it is impera-
tive that senior and experienced doctors are involved
in the care of women with placenta previa from the
outset.
Our study has demonstrated that, in addition to
women with previous CS, women with advanced
maternal age, women with birth intervals of less than
one year and women who had a previous placenta pre-
via are at a higher risk of developing placenta previa.
Nonetheless, our study suggests that the absolute risk
remains small. Women who had placenta previa in their
previous pregnancy were at the greatest risk of placenta
previa in a current pregnancy but less than 5 in 100 of
women with a previous placenta previa would be
expected to have this complication again. Clinicians
should consider and communicate these factors when
counseling their patients using appropriate and simpli-
fied risk statistics[79]. Our study quantifies this risk and
provides data that can be used to reassure women,
attending for pre-conception counseling clinics or
antenatal clinics as well as in pre-operative consent dis-
cussions for women undergoing CS.
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